Type a condition. We show you every compound claimed to help with it, and next to each one, the honest grade: approved, randomised trials, small human studies, animals only, or a lab bench. Same answer whether it flatters the peptide or not.
Most peptide sites use a single word — “studied” — to cover everything from a phase 3 trial to a dish of rat cells. These are the six tiers we use, and every compound on the site carries one.
Approved by the FDA with randomised human trial data behind the label.
13 compounds on this site
Randomised controlled human trials exist. Not necessarily approved, and not necessarily positive.
11 compounds on this site
Small, uncontrolled, foreign-registry or single-group human studies only.
15 compounds on this site
Preclinical animal and cell work. No meaningful human evidence.
7 compounds on this site
Cell culture, theory, or research-reagent status. Not tested in animals for this use, let alone people.
4 compounds on this site
Used widely without trials, with documented human harm reports.
1 compound on this site
Nine entries that show the full range — from drugs with tens of thousands of randomised patients behind them to compounds whose entire reputation rests on rodents.
A prescription GLP-1 with a real FDA label and some of the largest outcome trials in medicine.
An approved dual-receptor drug with the largest average weight loss of any approved agent.
A triple agonist in late-stage trials with the largest phase 2 weight loss ever published.
The recovery peptide everyone researches first. Robust in animals, untested in humans.
A thymosin β4 fragment carrying the reputation of the full peptide's animal research.
The anti-inflammatory tail of α-MSH, studied mainly in mouse colitis and skin models.
The best-supported cosmetic peptide — for skin, topically, at modest effect sizes.
The telomerase peptide. Extraordinary claims, Russian-only data, no Western replication.
The one mitochondrial peptide that made it to approval — for a rare genetic cardiomyopathy.
The dangerous part of peptides is rarely the compound — it is the decimal point. A 5 mg vial, 2 mL of water, a 250 mcg dose: get the conversion wrong and you are off by ten times. These do the conversion and nothing else.
Vial strength plus water plus your dose, out comes the exact syringe mark.
You drew to 14 units. How many micrograms was that, actually?
Choose the water volume that lands your dose on a big, readable mark.
How much accumulates, when it plateaus, how long washout takes.
Doses per vial, weeks of supply, cost per dose, and whether it outlasts 28 days.
Convert a mcg/kg figure from a paper into a total dose.
On 23–24 July 2026 the FDA’s Pharmacy Compounding Advisory Committee voted to recommend BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon for the 503A bulks list — against its own staff scientists’ written recommendation. It voted down DSIP. None of that is binding, and none of it changes what is legal today.
Read the tracker →